129 related articles for article (PubMed ID: 36301365)
1. Identification of anti-Helicobacter pylori antibody signatures in gastric intestinal metaplasia.
Song L; Song M; Rabkin CS; Chung Y; Williams S; Torres J; Corvalan AH; Gonzalez R; Bellolio E; Shome M; LaBaer J; Qiu J; Camargo MC
J Gastroenterol; 2023 Feb; 58(2):112-124. PubMed ID: 36301365
[TBL] [Abstract][Full Text] [Related]
2. Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H. pylori infection in patients with precancerous lesions.
Li S; Lu AP; Zhang L; Li YD
World J Gastroenterol; 2003 Apr; 9(4):755-8. PubMed ID: 12679926
[TBL] [Abstract][Full Text] [Related]
3. Mucosal IgA antibody against Helicobacter pylori in chronic gastritis and intestinal metaplasia detected by the Tes-Tape method in resection specimens after gastrectomy for gastric cancer.
Matsukura N; Onda M; Tokunaga A; Matsuda N; Yamashita K
Cancer; 1995 Mar; 75(6 Suppl):1472-7. PubMed ID: 7889477
[TBL] [Abstract][Full Text] [Related]
4. Use of Helicobacter pylori-specific antibodies in the evaluation of intestinal metaplasia and gastric dysplasia.
Barbosa J; Dinis-Ribeiro M; Guilherme M; Filipe T; Lomba-Viana R; Guimarães MA; Lopes C
Br J Biomed Sci; 2003; 60(4):175-9. PubMed ID: 14725331
[TBL] [Abstract][Full Text] [Related]
5.
Song L; Song M; Rabkin CS; Williams S; Chung Y; Van Duine J; Liao LM; Karthikeyan K; Gao W; Park JG; Tang Y; Lissowska J; Qiu J; LaBaer J; Camargo MC
J Proteome Res; 2021 Jan; 20(1):409-419. PubMed ID: 33108201
[TBL] [Abstract][Full Text] [Related]
6. Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer.
Adamsson J; Lundin SB; Hansson LE; Sjövall H; Svennerholm AM
Helicobacter; 2013 Feb; 18(1):73-82. PubMed ID: 23067268
[TBL] [Abstract][Full Text] [Related]
7. [Helicobacter pylori genotypes in non atrophic gastritis are different of the found in peptic ulcer, premalignant lesions and gastric cancer in Colombia].
Cittelly DM; Huertas MG; Martínez JD; Oliveros R; Posso H; Bravo MM; Orozco O
Rev Med Chil; 2002 Feb; 130(2):143-51. PubMed ID: 11974526
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Helicobacter pylori infection in patients with precancerous changes and gastric cancer.
Farinati F; Valiante F; Germanà B; Della Libera G; Baffa R; Rugge M; Plebani M; Vianello F; Di Mario F; Naccarato R
Eur J Cancer Prev; 1993 Jul; 2(4):321-6. PubMed ID: 8358284
[TBL] [Abstract][Full Text] [Related]
9. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A
Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643
[TBL] [Abstract][Full Text] [Related]
10. Progression of atrophic gastritis and intestinal metaplasia drives Helicobacter pylori out of the gastric mucosa.
Kang HY; Kim N; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
Dig Dis Sci; 2006 Dec; 51(12):2310-5. PubMed ID: 17080249
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing.
Park CH; Lee AR; Lee YR; Eun CS; Lee SK; Han DS
Helicobacter; 2019 Feb; 24(1):e12547. PubMed ID: 30440093
[TBL] [Abstract][Full Text] [Related]
12. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
13. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran.
Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z
Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143
[TBL] [Abstract][Full Text] [Related]
14. Atrophic gastritis in Helicobacter pylori-infected children.
Hsieh H; Yang HB; Sheu BS; Yang YJ
Helicobacter; 2022 Jun; 27(3):e12885. PubMed ID: 35306717
[TBL] [Abstract][Full Text] [Related]
15. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
[TBL] [Abstract][Full Text] [Related]
16. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori antibody responses and evolution of precancerous gastric lesions in a Chinese population.
Pan KF; Formichella L; Zhang L; Zhang Y; Ma JL; Li ZX; Liu C; Wang YM; Goettner G; Ulm K; Classen M; You WC; Gerhard M
Int J Cancer; 2014 May; 134(9):2118-25. PubMed ID: 24155048
[TBL] [Abstract][Full Text] [Related]
18. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
19. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial).
Aumpan N; Vilaichone RK; Pornthisarn B; Chonprasertsuk S; Siramolpiwat S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N; Ratana-Amornpin S; Miftahussurur M; Mahachai V; Yamaoka Y
PLoS One; 2021; 16(8):e0255601. PubMed ID: 34379655
[TBL] [Abstract][Full Text] [Related]
20. IgG2 response and low IgG titre specific to Helicobacter pylori CagA as serological markers for gastric cancer.
de la Cruz-Herrera CF; Flores-Luna L; Gutierrez-Xicotencatl L; Chihu-Amparan L; Sánchez-Aleman MA; Lazcano-Ponce E; Torres J; Ayala G
J Med Microbiol; 2013 Apr; 62(Pt 4):591-598. PubMed ID: 23288428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]